Please login to the form below

Not currently logged in
Email:
Password:

Patients should have a say in their medication, claims NICE

Also states health practitioners should be able to share information

NICE logo

New guidelines published by NICE today state that putting patients at the centre of medication decision could ensure they get the best outcomes.

The guidelines say that shared decision-making should be based on the best evidence available, taking into consideration the patient's individual needs, preferences and values.

Paul Chrisp, programme director for the medicines and prescribing centre at NICE, said: “The NICE guideline on medicines optimisation sets out what needs to be done by all health and social care practitioners and organisations to put in place the person-centred systems and processes required for the optimal use of medicines.

“The guideline also supports the safe and effective management of long-term conditions and when people are taking a number of medicines to treat more than one condition.”

Poor communication between patients and healthcare providers can be caused in instances including patients changing their geographical location, when up to 70% have experienced an error or unintentional change in their medication.

In light of this, the guidelines recommend that health and social care practitioners should be able to share relevant information about patients and their medication in specific circumstances in order to optimise the impact of medicines, minimise the number of medicine-related problems and reduce waste.

Dr Weeliat Chong, chair of NICE medicines optimisation committee and chief pharmacist of Humber NHS foundation trust, added: “Over the past 10 years there have been many strategies, models and concepts for optimising a person's medicines. Medicines optimisation is not a new concept.

“This guideline makes a series of recommendations based on a review of all the relevant clinical and health economic evidence of what works. Involving people in decisions about their medicines to enable them to get the best possible outcomes is a key component of the guideline.”

Article by
Kirstie Pickering

4th March 2015

From: Healthcare

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Research Partnership

We are one of the largest independent healthcare market research and consulting agencies in the world. Trusted partner to the...

Latest intelligence

The new pharma marketing playbook
Learn about the 5 areas that must be in your pharma marketing playbook...
Pharma needs to evolve from customer-centricity to stakeholder-centricity
Customer-centricity and patient-centricity is no longer enough for pharma sales and marketing strategies as digital promises better customer experiences for all pharma stakeholders....
5 health behavioural factors to incorporate in your marketing
Achieve real health behaviour change by including these elements in your pharmaceutical marketing....

Infographics